Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Assets (2016 - 2025)

Apyx Medical's Non-Current Assets history spans 16 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 1.8% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $6.6 million, down 1.8%, while the annual FY2025 figure was $6.6 million, 1.8% down from the prior year.
  • Non-Current Assets reached $6.6 million in Q4 2025 per APYX's latest filing, down from $6.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $9.5 million in Q2 2023 to a low of $4.1 million in Q1 2023.
  • Average Non-Current Assets over 5 years is $7.8 million, with a median of $8.0 million recorded in 2021.
  • Peak YoY movement for Non-Current Assets: crashed 49.91% in 2023, then soared 114.27% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $8.0 million in 2021, then grew by 10.26% to $8.8 million in 2022, then dropped by 18.82% to $7.1 million in 2023, then dropped by 5.71% to $6.7 million in 2024, then fell by 1.8% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Non-Current Assets are $6.6 million (Q4 2025), $6.8 million (Q3 2025), and $6.6 million (Q2 2025).